03/02/2015 - 12:08pm

The implementation of an e-prescribing mandate in New York hits a snag as state legislators agree to a delay.

03/02/2015 - 8:42am

Mylan on Friday announced the successful completion of the acquisition of Abbott Laboratories' non-U.S. developed markets specialty and branded generics business.

02/27/2015 - 4:25pm

Epic Pharma on Friday launched two generics: a schedule II pain reliever and a calcium channel blocker. 

02/27/2015 - 10:24am

Camber Pharmaceuticals' latest generic drug launch is used to treat pulmonary hypertension.

02/26/2015 - 5:05pm

Congress introdues legislation to protect FDA user fees from sequestration. 

02/26/2015 - 2:27pm

A survey found that chronic disease patients who use digital technology to manage their disease state feel "healthier."

 

02/26/2015 - 12:03pm

Greenstone, a subsidiary of Pfizer, announced the introduction of trandolapril/verapamil hydrochloride extended-release tablets to its line of generic pharmaceutical products. 

 

02/25/2015 - 11:45am

In 10 years, the percentage of opioid analgesic users who used an opioid analgesic stronger than morphine increased from 17% to 37%, NCHS reported Wednesday. 

02/24/2015 - 3:42pm

Mylan has been appointed as the exclusive India distributor of Sovaldi (sofosbuvir 400mg tablets) and Harvoni (ledipasvir 90mg/sofosbuvir 400 mg tablets) for the treatment of chronic hepatitis C, by Gilead Sciences.